440345-40-4

Upstream product

• 130177-78-5 O-(2-O-Acetyl-3,4,6-tri-O-benzyl-α-D-galactopyranosyl) trichloroacetimidate 
• 440345-39-1 methyl 2-acetamido-2-deoxy-3-O-benzyl-6-O-tert-butyldimethylsilyl-4-O-(2-O-acetyl-3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 

Downstream Products

• 440345-41-5 methyl 2-acetamido-2-deoxy-3-O-benzyl-4-O-(3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 
• 440345-45-9 methyl 2-acetamido-2-deoxy-3-O-benzyl-4-O-(3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-6-di-O-(2-O-methanesulfonyl-ethane)-β-D-glucopyranoside 
• 440345-46-0 methyl 2-acetamido-2-deoxy-3-O-benzyl-4-O-(3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-2',6-di-O-(ethane-1,2-diyl)-β-D-glucopyranoside 
• 440345-43-7 methyl 2-acetamido-2-deoxy-3-O-benzyl-2',6-anhydro-4-O-(3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 
• 704907-03-9 N-[(2R,3R,4R,5R,6R)-4-Benzyloxy-5-((2S,3R,4R,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-hydroxy-tetrahydro-pyran-2-yloxy)-6-(methanesulfonylamino-methyl)-2-methoxy-tetrahydro-pyran-3-yl]-acetamide 
• 704906-96-7 N-[(2R,3R,4R,5R,6R)-6-(Acetylamino-methyl)-4-benzyloxy-5-((2S,3R,4R,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-hydroxy-tetrahydro-pyran-2-yloxy)-2-methoxy-tetrahydro-pyran-3-yl]-acetamide 
• 704907-09-5 N-[(2R,3R,4R,5R,6R)-4-Benzyloxy-5-((2S,3R,4R,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-hydroxy-tetrahydro-pyran-2-yloxy)-6-formylaminomethyl-2-methoxy-tetrahydro-pyran-3-yl]-acetamide 
• 704907-21-1 N-[(2R,3R,4R,5R,6R)-4-Benzyloxy-5-((2S,3R,4S,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-methoxy-tetrahydro-pyran-2-yloxy)-6-formylaminomethyl-2-methoxy-tetrahydro-pyran-3-yl]-acetamide 
• 704907-17-5 N-[(2R,3R,4R,5R,6R)-6-Aminomethyl-4-benzyloxy-5-((2S,3R,4S,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-methoxy-tetrahydro-pyran-2-yloxy)-2-methoxy-tetrahydro-pyran-3-yl]-acetamide 
• 704907-13-1 N-[(2R,3R,4R,5R,6R)-6-Azidomethyl-4-benzyloxy-5-((2S,3R,4S,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-methoxy-tetrahydro-pyran-2-yloxy)-2-methoxy-tetrahydro-pyran-3-yl]-acetamide 
• 704906-73-0 N-[(2R,3R,4R,5S,6R)-4-Benzyloxy-5-((2S,3R,4R,5S,6R)-4,5-bis-benzyloxy-6-benzyloxymethyl-3-hydroxy-tetrahydro-pyran-2-yloxy)-2-methoxy-6-methoxymethyl-tetrahydro-pyran-3-yl]-acetamide 
• 665019-68-1 methyl 2-acetamido-6-azido-3-O-benzyl-2,6-dideoxy-4-O-(2-O-acetyl-3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 
• 665019-69-2 methyl 2-acetamido-6-azido-3-O-benzyl-2,6-dideoxy-4-O-(3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 
• 665019-70-5 methyl 2-acetamido-6-amino-3-O-benzyl-2,6-dideoxy-4-O-(3,4,6-tri-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 

Relevant academic research and scientific papers

Glycosyltransferase activity can be selectively modulated by chemical modifications of acceptor substrates

A range of N-acetyllactosamine derivatives, which are modified by a wide range of functionalities at C-2′ and C-6, have been synthesised and the kinetic parameters of transfer catalysed by recombinant α-2,6-sialyltransferase and α-1,3-fucoyltra

α-(2,6)-sialyltransferase-catalyzed sialylations of conformationally constrained oligosaccharides

It is demonstrated that conformationally restricted oligosaccharides can act as acceptors for glycosyltransferases. Correlation of the conformational properties of N-acetyl lactosamine (Galβ/(1-4)GlcNAc, LacNAc) and several preorganized derivatives with t